Pluristem Therapeutics Inc. Announces Proposed Public Offering of Common Stock and Warrants and Concurrent Registered Direct Offering of Common Stock – Nasdaq

By /

Pluristem Therapeutics Inc. Announces Proposed Public Offering of Common Stock and Warrants and Concurrent Registered Direct Offering of Common Stock Nasdaq

HAIFA, Israel, April 03, 2019– Pluristem Therapeutics Inc., a leading regenerative medicine company developing novel placenta-based cell therapy.

About The Author

Scroll to Top